Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Benzimidazolone Activators of Chloride Secretion: Potential Therapeutics for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Sangeeta Singh, Colin A. Syme, Ashvani K. Singh, Daniel C. Devor and Robert J. Bridges
Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 600-611;
Sangeeta Singh
Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Colin A. Syme
Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Ashvani K. Singh
Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Daniel C. Devor
Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Robert J. Bridges
Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 296, Issue 2
1 Feb 2001
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Benzimidazolone Activators of Chloride Secretion: Potential Therapeutics for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Sangeeta Singh, Colin A. Syme, Ashvani K. Singh, Daniel C. Devor and Robert J. Bridges
Journal of Pharmacology and Experimental Therapeutics February 1, 2001, 296 (2) 600-611;
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Benzimidazolone Activators of Chloride Secretion: Potential Therapeutics for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Sangeeta Singh, Colin A. Syme, Ashvani K. Singh, Daniel C. Devor and Robert J. Bridges
Journal of Pharmacology and Experimental Therapeutics February 1, 2001, 296 (2) 600-611;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement